A Post-Intervention Surveillance Study Regarding the Acquisition Rate of ESBL-KP, Ecoli

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

NCT00573521 ·Status: COMPLETED

Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae

NCT01138566 ·Status: UNKNOWN

Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change

NCT01392118 ·Status: UNKNOWN

Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

NCT04764500 ·Status: ACTIVE_NOT_RECRUITING

Study of Antibiotic Utilization Measures and Control of ESBLs in China

NCT00488813 ·Status: COMPLETED ·Phase: PHASE4

The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children

NCT00894036 ·Status: UNKNOWN

Optimization Management Study of Community Urinary Tract Infections Spectrum

NCT03655548 ·Status: COMPLETED

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?

NCT04699981 ·Status: UNKNOWN ·Phase: NA

Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients

NCT01838213 ·Status: COMPLETED

Transmission of ESBL-producing Enterobacteriaceae

NCT03465683 ·Status: RECRUITING

Fecal ESBL Resurgence During Antibiotic Treatment

NCT03206879 ·Status: TERMINATED

Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice

NCT01531023 ·Status: COMPLETED

Urinary Tract Infections Caused by ESBL-producing Enterobacteria

NCT03501901 ·Status: COMPLETED

Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time

NCT01611025 ·Status: UNKNOWN

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

NCT01820793 ·Status: TERMINATED ·Phase: NA

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

NCT03338738 ·Status: COMPLETED ·Phase: NA

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

NCT06252428 ·Status: COMPLETED

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study

NCT01764490 ·Status: COMPLETED

Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture of Membranes : A French Multicenter Cohort Study

NCT07200999 ·Status: NOT_YET_RECRUITING

Effects of H.Pylori Eradication on Microbiome

NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study

NCT05521139 ·Status: COMPLETED

Study Evaluating the Etiology of Intra-Abdominal Infections

NCT00244088 ·Status: COMPLETED

Antibiotic Resistant Community-Acquired E. Coli

NCT00298103 ·Status: COMPLETED

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

NCT02456818 ·Status: UNKNOWN

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

NCT01961206 ·Status: COMPLETED